Matches in Wikidata for { <http://www.wikidata.org/entity/Q89660392> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q89660392 description "artículu científicu espublizáu n'avientu de 2017" @default.
- Q89660392 description "scientific article published on 01 December 2017" @default.
- Q89660392 description "wetenschappelijk artikel" @default.
- Q89660392 description "наукова стаття, опублікована в грудні 2017" @default.
- Q89660392 name "NICE issues positive recommendation for XELJANZ®▼(tofacitinib citrate) as a new treatment option for adults with severe rheumatoid arthritis" @default.
- Q89660392 name "NICE issues positive recommendation for XELJANZ®▼(tofacitinib citrate) as a new treatment option for adults with severe rheumatoid arthritis" @default.
- Q89660392 type Item @default.
- Q89660392 label "NICE issues positive recommendation for XELJANZ®▼(tofacitinib citrate) as a new treatment option for adults with severe rheumatoid arthritis" @default.
- Q89660392 label "NICE issues positive recommendation for XELJANZ®▼(tofacitinib citrate) as a new treatment option for adults with severe rheumatoid arthritis" @default.
- Q89660392 prefLabel "NICE issues positive recommendation for XELJANZ®▼(tofacitinib citrate) as a new treatment option for adults with severe rheumatoid arthritis" @default.
- Q89660392 prefLabel "NICE issues positive recommendation for XELJANZ®▼(tofacitinib citrate) as a new treatment option for adults with severe rheumatoid arthritis" @default.
- Q89660392 P1433 Q89660392-DC9DE990-C653-4F3F-B07C-0A56AC9707B9 @default.
- Q89660392 P1476 Q89660392-5467FDBC-A11F-409E-B7B5-3C9F9CD25292 @default.
- Q89660392 P304 Q89660392-EC730A1C-C442-4BD4-908B-21CE90606BD3 @default.
- Q89660392 P31 Q89660392-58E26A82-CD56-425E-841F-D88D88A27BB0 @default.
- Q89660392 P356 Q89660392-0D140771-9D22-4B4F-AE63-3AFD9A678807 @default.
- Q89660392 P433 Q89660392-D329F1E3-14F4-4D17-9614-27009EACA1F4 @default.
- Q89660392 P478 Q89660392-FDD3D6A4-AF1E-4F3E-B00B-CA7B63041B92 @default.
- Q89660392 P577 Q89660392-B88C1B2A-1F6D-4D5B-937F-046628621F83 @default.
- Q89660392 P698 Q89660392-87B3EFE5-E3F4-4AA8-B0C3-8C9EB3085C77 @default.
- Q89660392 P921 Q89660392-D0E62A7C-DBAF-47C3-BA69-B3DD8249CBE8 @default.
- Q89660392 P356 KEX407 @default.
- Q89660392 P698 29040714 @default.
- Q89660392 P1433 Q7320492 @default.
- Q89660392 P1476 "NICE issues positive recommendation for XELJANZ®▼(tofacitinib citrate) as a new treatment option for adults with severe rheumatoid arthritis" @default.
- Q89660392 P304 "e49" @default.
- Q89660392 P31 Q13442814 @default.
- Q89660392 P356 "10.1093/RHEUMATOLOGY/KEX407" @default.
- Q89660392 P433 "12" @default.
- Q89660392 P478 "56" @default.
- Q89660392 P577 "2017-12-01T00:00:00Z" @default.
- Q89660392 P698 "29040714" @default.
- Q89660392 P921 Q187255 @default.